NDAORALTABLET
Approved
Apr 1960
Lifecycle
LOE Approaching
Competitive Pressure
30/100
Data completeness
1/8 — Limited
Drug data last refreshed 2d ago · AI intelligence enriched 3w ago
AI summarySynthesized from FDA + DailyMed + ClinicalTrials.gov data
ROBAXISAL is a fixed-dose combination tablet containing aspirin (analgesic/anti-inflammatory) and methocarbamol (skeletal muscle relaxant), approved in 1960 for oral use. The combination targets musculoskeletal pain and muscle spasm by combining peripheral analgesic action with centrally-acting muscle relaxation. It is indicated for patients requiring concurrent pain relief and muscle relaxant therapy.
LOE Approaching
Approaching loss of exclusivity with moderate competitive pressure (30/100) signals transition planning and potential downsizing or portfolio rebalancing within the brand team.
Mechanism of Action
Mechanism of action data is being enriched from DailyMed and FDA sources. Check back soon for updated drug intelligence.
Indications
Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.
Career Relevance
Working on ROBAXISAL offers limited career growth due to its LOE-approaching status and absence of linked job postings; most roles focus on defending market share and managing decline. This assignment is best suited for professionals seeking stability in a mature portfolio rather than high-growth opportunity.
Brand ManagerField Sales Representative
Worked on ROBAXISAL at R-Pharm US? Share your interview experience or compensation data (+7 days Pro)
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.